Ondine Biomedical Inc. (OBI.L) LSE

8.02

+0.02(+0.25%)

Updated at January 15 09:57AM

Currency In GBp

Valuation

Market Cap43.23M
Enterprise Value33.63M
P/E Ratio-2.15
PEG Ratio-0.02
Price/Sales Ratio31.25
Price/Book Ratio5.97
Enterprise/Revenue26.56
Enterprise/EBITDA-2.94

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-9.32
Operating Margin-9.49

Management Effectiveness

Return On Assets-1.49
Return On Equity-4.26

Income Statement

Revenue2.05M
Revenue/Share0.01
Gross Profit1.32M
EBITDA-18.49M
Net Income-19.1M
Diluted EPS-0.07

Balance Sheet

Total Cash9.77M
Total Cash/Share0.04
Total Debt168,000
Total Debt/Equity0.02
Current Ratio2.05
Book Value Per Share0.03

Price History

52-Week Change-27.27
52-Week High18.5
52-Week Low7.61
Moving Average 50 Days10.46
Moving Average 200 Days11.95

Statistics

Average Volume189,997
Shares Outstanding428.31M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A